Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.
2.

Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.

Beylot M, Khalfallah Y, Riou JP, Cohen R, Normand S, Mornex R.

J Clin Endocrinol Metab. 1986 Jul;63(1):9-15.

PMID:
3519651
3.
4.

Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.

Owen OE, Reichard GA Jr, Markus H, Boden G, Mozzoli MA, Shuman CR.

J Clin Invest. 1973 Oct;52(10):2606-16.

5.
6.

Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.

Miles JM, Nissen SL, Rizza RA, Gerich JE, Haymond MW.

Diabetes. 1983 Mar;32(3):197-205.

PMID:
6298041
7.

Evidence against important catecholamine compensation for absent glucagon counterregulation.

De Feo P, Perriello G, Torlone E, Fanelli C, Ventura MM, Santeusanio F, Brunetti P, Gerich JE, Bolli GB.

Am J Physiol. 1991 Feb;260(2 Pt 1):E203-12.

PMID:
1996624
8.

Effect of ketone bodies on glucose production and utilization in the miniature pig.

Müller MJ, Paschen U, Seitz HJ.

J Clin Invest. 1984 Jul;74(1):249-61.

9.

The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle.

Nosadini R, Alberti KG, Johnston DG, Del Prato S, Marescotti C, Duner E.

Metabolism. 1981 Jun;30(6):563-7.

PMID:
6112656
10.

GLP-1 does not not acutely affect insulin sensitivity in healthy man.

Orskov L, Holst JJ, Møller J, Orskov C, Møller N, Alberti KG, Schmitz O.

Diabetologia. 1996 Oct;39(10):1227-32.

PMID:
8897012
11.

Contribution of cortisol to glucose counterregulation in humans.

De Feo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, Brunetti P, Gerich JE, Bolli GB.

Am J Physiol. 1989 Jul;257(1 Pt 1):E35-42.

PMID:
2665516
12.

Fatty acid-independent inhibition of hepatic ketone body production by insulin in humans.

Keller U, Gerber PP, Stauffacher W.

Am J Physiol. 1988 Jun;254(6 Pt 1):E694-9.

PMID:
3287950
13.

Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.

Paolisso G, Buonocore S, Gentile S, Sgambato S, Varricchio M, Scheen A, D'Onofrio F, Lefèbvre PJ.

Diabetologia. 1990 May;33(5):272-7.

PMID:
2198186
14.

Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.

Orskov L, Alberti KG, Mengel A, Møller N, Pedersen O, Rasmussen O, Seefeldt T, Schmitz O.

Diabetologia. 1991 Jul;34(7):521-6.

PMID:
1916058
15.

Postexercise dose-response relationship between plasma glucose and insulin secretion.

Mikines KJ, Farrell PA, Sonne B, Tronier B, Galbo H.

J Appl Physiol (1985). 1988 Mar;64(3):988-99.

PMID:
3284873
16.

Influence of ketone body infusion on plasma growth hormone and glucagon in man.

Quabbe HJ, Trompke M, Luyckx AS.

J Clin Endocrinol Metab. 1983 Sep;57(3):613-8.

PMID:
6348066
17.

Metabolic effects of low-dose incremental insulin infusion in diabetic man.

Hale PJ, Black E, Nattrass M.

Horm Metab Res. 1986 Feb;18(2):129-33.

PMID:
3516823
18.

Effect of insulin and acute diabetes on plasma FFA and ketone bodies in the fasting rat.

Bieberdorf FA, Chernick SS, Scow RO.

J Clin Invest. 1970 Sep;49(9):1685-93.

19.
20.

Hypoketonaemic effect of L-alamine. Specific decrease in blood concentrations of 3-hydroxybutyrate in the rat.

Ozand PT, Reed WD, Girard J, Hawkins RL, Collins RM Jr, Tildon JT, Cornblath M.

Biochem J. 1977 Jun 15;164(3):557-64.

Supplemental Content

Support Center